The Main Classes of Research Peptides: A Field Guide

Anyone new to peptide research runs into the same wall: dozens of compounds with unfamiliar names — retatrutide, ipamorelin, BPC-157, MOTS-c — and no obvious way to tell how they relate to one another. They are not a random list. They sort into a handful of families, and once you see the families, the whole field becomes far easier to navigate.

This is a plain-language map of how researchers group these compounds, what defines each class, and how peptides differ from the proteins and cofactors they are often lumped together with. It is educational only and describes mechanisms studied in laboratory research on research-use-only materials.

First: what actually makes something a peptide

A peptide is a chain of amino acids joined by peptide bonds — the same chemistry that builds proteins. The only real distinction is length. By loose convention, chains up to roughly 50 amino acids are called peptides; longer chains are called proteins. There is no hard line, and some compounds sit awkwardly across it.

Length matters because it determines behavior. Short chains are small enough to be synthesized reliably in a lab, and short enough that a single sequence change can dramatically alter which receptor the molecule fits. Sequence is function: the order of amino acids determines the three-dimensional shape, and that shape determines what the peptide binds to.

One important caveat, because it causes constant confusion: not everything sold alongside peptides is a peptide. NAD+, for instance, is a nucleotide-derived coenzyme, not an amino acid chain at all. It appears in the same catalogs because it is studied in overlapping areas of metabolic research, not because it is chemically related.

Class 1: Incretin and metabolic receptor agonists

The most discussed family right now. These are analogs of naturally occurring gut and pancreatic hormones that signal through the GLP-1, GIP, and glucagon receptors — a signaling axis central to metabolic research.

They are usually described by how many receptors they engage:

• Single agonists — act at GLP-1 alone (semaglutide belongs here)
• Dual agonists — tirzepatide engages both GIP and GLP-1 receptors
• Triple agonists — retatrutide adds glucagon receptor activity to the other two

The research interest is in how engaging multiple receptors simultaneously changes downstream signaling compared with engaging one. These are structurally modified to resist rapid enzymatic breakdown, which is why they persist far longer than the native hormones they are modeled on.

Class 2: Growth-hormone axis peptides

This family is frequently misunderstood, because it contains two mechanistically different groups that are often mentioned in the same breath.

GHRH analogs mimic growth-hormone-releasing hormone and act on the pituitary GHRH receptor. Tesamorelin and CJC-1295 sit here.

Growth hormone secretagogues (GHS) act instead at the ghrelin receptor (GHS-R). Ipamorelin is the common example.

Because the two act through separate receptors on the same axis, they are frequently studied together — the CJC-1295 and ipamorelin pairing is the best-known example of that combined-pathway approach.

Class 3: Cytoprotective and tissue-repair peptides

These are studied in research on cellular protection, angiogenesis, and extracellular matrix dynamics.

• BPC-157 — a synthetic fragment derived from a sequence identified in gastric juice, investigated for cytoprotective signaling
• TB-500 (thymosin beta-4) — studied for its role in actin regulation and cell migration

They are often researched in parallel because they act on different parts of the same repair-related biology — one on cytoprotective pathways, the other on cytoskeletal dynamics.

Class 4: Melanocortin receptor agonists

The melanocortin system comprises five receptor subtypes (MC1R through MC5R) involved in pigmentation, energy balance, and inflammatory signaling. Analogs of alpha-melanocyte-stimulating hormone (α-MSH) engage these receptors with varying selectivity.

Melanotan II is the widely studied example — notable in research precisely because it is non-selective, engaging several melanocortin subtypes rather than one.

Class 5: Mitochondrial-derived peptides

A genuinely unusual class. These are encoded not in nuclear DNA but in the mitochondrial genome — a discovery that reframed mitochondria as signaling organelles rather than purely energy producers.

MOTS-c is the most studied, investigated in research on metabolic homeostasis and cellular stress response. Humanin is another member of the same family.

Class 6: Matrix and copper-binding peptides

GHK-Cu is a naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) that binds copper(II). It is studied in research on extracellular matrix remodeling and antioxidant signaling. Its defining feature is the metal complex — the copper ion is integral to the activity being studied, not an additive.

Class 7: Neuropeptides and nootropic-class compounds

Short peptides studied in neurological and neurochemical research:

• Selank — a synthetic analog of the immune peptide tuftsin
• Semax — derived from the ACTH(4–10) fragment, with the hormonal activity of full ACTH removed

Both illustrate a common design strategy: take a natural sequence, keep the fragment responsible for the signaling of interest, and discard the rest.

Why so many end in “-tide”

Not an accident. International nonproprietary naming conventions use the -tide stem for peptide compounds — semaglutide, tirzepatide, retatrutide. Sub-stems carry more information: -glutide signals a GLP-1 analog, -relin indicates a releasing-hormone analog (tesamorelin, ipamorelin).

Once you know the convention, an unfamiliar name tells you roughly what family it belongs to before you look anything up.

How peptides are engineered to last longer

Native peptides are broken down quickly by peptidase enzymes. Research analogs are commonly modified to resist that:

• Amino acid substitution — swapping a residue at a known cleavage site
• Acylation — attaching a fatty acid chain that promotes albumin binding
• D-amino acids — mirror-image residues that peptidases do not recognize
• Cyclization — joining the ends into a ring, restricting shape and slowing degradation
• DAC (drug affinity complex) — a linker enabling covalent binding to serum albumin

This is why the CJC-1295 “with DAC” and “no-DAC” distinction exists, and why the two are not interchangeable in a research protocol.

Why they arrive as lyophilized powder

Peptide bonds hydrolyze in solution. Freeze-drying removes water and stabilizes the material for storage and shipping. That is also why reconstitution technique and storage conditions materially affect what you are actually working with — covered in Reconstitution & Storage.

The vocabulary, briefly

• Agonist — binds a receptor and activates it
• Antagonist — binds a receptor and blocks it
• Analog — structurally modified version of a natural compound
• Fragment — a section of a longer natural sequence
• Mimetic — reproduces an effect without sharing the original structure
• Selectivity — how narrowly a compound engages one receptor over related subtypes

Putting the map together

Nearly every compound you encounter belongs to one of these families, and the family tells you what question researchers are asking with it — metabolic receptor signaling, the growth-hormone axis, repair biology, melanocortin pathways, mitochondrial signaling, matrix remodeling, or neurochemistry.

Start from the class rather than the compound name, and the field stops looking like a list to memorize and starts looking like a structure to understand.

This article is educational and applies to research-use-only materials. Nothing here describes use in humans or animals. Any material used in laboratory work should be supported by lot-specific analytical documentation. For a deeper reference, see the free Noverix Scientific Guide.